These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9440549)

  • 1. Immunohistology of skin and oral biopsies in graft-versus-host disease after bone marrow transplantation and cytokine therapy.
    Yamada H; Chihara J; Hamada K; Matsukura M; Yudate T; Maeda K; Tubaki K; Tezuka T
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S73-6. PubMed ID: 9440549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
    Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
    Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation.
    Favre A; Cerri A; Bacigalupo A; Lanino E; Berti E; Grossi CE
    Am J Surg Pathol; 1997 Jan; 21(1):23-34. PubMed ID: 8990138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation.
    Girolomoni G; Pincelli C; Zambruno G; Andreani M; Giardini C; Lucarelli G; Giannetti A
    J Dermatol; 1991 Jun; 18(6):314-23. PubMed ID: 1939860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR expression in epidermal keratinocytes after allogeneic bone marrow transplantation. Relationship to histology, rash, marrow purging, and systemic graft-versus-host disease.
    Sloane JP; Elliott CJ; Powles R
    Transplantation; 1988 Dec; 46(6):840-4. PubMed ID: 3061079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICAM-1 expression on epidermal keratinocytes in cutaneous graft-versus-host disease.
    Norton J; Sloane JP
    Transplantation; 1991 Jun; 51(6):1203-6. PubMed ID: 1675503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus.
    Mattsson T; Sundqvist KG; Heimdahl A; Dahllöf G; Ljungman P; Ringdén O
    Arch Oral Biol; 1992; 37(7):539-47. PubMed ID: 1359859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistology of skin and rectum biopsies in bone marrow transplant recipients.
    Leskinen R; Taskinen E; Volin L; Ruutu T; Häyry P
    APMIS; 1992 Dec; 100(12):1115-22. PubMed ID: 1492980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocyte apoptosis following bone marrow transplantation: evidence for CTL-dependent and -independent pathways.
    Jerome KR; Conyers SJ; Hansen DA; Zebala JA
    Bone Marrow Transplant; 1998 Aug; 22(4):359-66. PubMed ID: 9722071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease.
    Carayol G; Bourhis JH; Guillard M; Bosq J; Pailler C; Castagna L; Vernant JP; Pico JL; Hayat M; Chouaib S; Caignard A
    Transplantation; 1997 May; 63(9):1307-13. PubMed ID: 9158026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoelectron microscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation.
    Takata M; Imai T; Hirone T
    J Clin Pathol; 1993 Sep; 46(9):801-5. PubMed ID: 7693765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
    Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
    Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical study of haploidentical transplantation using granulocyte colony-stimulating factor stimulating donor bone marrow].
    Chen H; Ji S; Wang H
    Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):760-3. PubMed ID: 11930684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation rates in epidermis of patients with graft-versus-host disease, non-specific inflammation and normal skin.
    Jakic-Razumovic J; Browne MD; Sale GE
    Bone Marrow Transplant; 1992 Jul; 10(1):27-31. PubMed ID: 1515875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
    Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications.
    Ringdén OT; Le Blanc K; Remberger M
    Exp Hematol; 2005 May; 33(5):505-12. PubMed ID: 15850828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.